共 50 条
- [21] A RETROSPECTIVE COMPARISON OF ADJUVANT CHEMOTHERAPEUTIC REGIMEN FOR NON-SMALL CELL LUNG CANCER (NSCLC): PACLITAXEL PLUS PLATINUM VERSUS VINORELBINE PLUS CISPLATINJOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S580 - S580Chang, Won JinChoi, Moon KiHong, Jung YongKim, MoonjinLee, Su JinPark, SilviaKim, SungminLee, Ji YunLim, Sung HeeAhn, Jin SeokPark, KeunchilAhn, Myung-JuSun, Jong-Mu
- [22] Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: The Japanese taxotere lung cancer study groupJOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) : 254 - 261Kubota, KWatanabe, KKunitoh, HNoda, KIchinose, YKatakami, NSugiura, TKawahara, MYokoyama, AYokota, SYoneda, SMatsui, KKudo, SShibuya, MIsobe, TSegawa, YNishiwaki, YOhashi, YNiitani, H
- [23] Gemcitabine plus cisplatin in patients with state IIIB/IV non-small cell lung cancer (NSCLC)ANNALS OF ONCOLOGY, 2004, 15 : 194 - 194Teixeira, EncarnacaoGoncalves, InesMayor, Renato SottoMelo, RicardoLopes, CarlosPinto, Ana
- [24] THE BENEFITS OF BEVACIZUMAB PLUS CISPLATIN AND GEMCITABINE (BCG) VERSUS CETUXIMAB PLUS VINORELBINE AND CISPLATIN (CVC) IN PATIENTS WITH ADVANCED OR RECURRENT NON-SMALL CELL LUNG CANCER (NSCLC) IN SWEDEN: RESULTS FROM A COST-EFFECTIVENESS ANALYSISVALUE IN HEALTH, 2009, 12 (07) : A272 - A272Nuijten, M. J.Holmberg, C.Walzer, S.
- [25] Cisplatin plus vinorelbine chemotherapy for non-small cell lung cancer17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 643 - 646Pereira, JRGampel, OMartins, SJIkari, FKNikaedo, SMPaschoalini, M
- [26] Our experience of chemotherapy (CT) with vinorelbine (V) alone and vinorelbine (V) plus cisplatin (C) for non-small-cell lung cancer (NSCLC) patients (pts)INTERNATIONAL JOURNAL OF CANCER, 2002, : 413 - 414Marenich, AGorbounova, VBesova, NBreder, VKozlov, D
- [27] Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung CancerJOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (19) : 2187 - +Kenmotsu, HirotsuguYamamoto, NobuyukiYamanaka, TakeharuYoshiya, KatsuoTakahashi, ToshiakiUeno, TsuyoshiGoto, KoichiDaga, HarukoIkeda, NorihikoSugio, KenjiSeto, TakashiToyooka, ShinichiDate, HiroshiMitsudomi, TetsuyaOkamoto, IsamuYokoi, KoheiSaka, HideoOkamoto, HiroakiTakiguchi, YuichiTsuboi, Masahiro
- [28] CISPLATIN PLUS EPIRUBICIN AND ETOPOSIDE FOLLOWED BY IRRADIATION PLUS LONIDAMINE IN STAGE-III NONSMALL CELL LUNG-CANCERONCOLOGY, 1993, 50 (01) : 10 - 13FILIPAZZI, VCATTANEO, MTRHO, BFRONTINI, LDADDA, DISA, LSCAPATICCI, RLEGNANI, WCALZAVARA, MPBERNI, FPIAZZA, E
- [29] Cisplatin plus vinorelbine as induction treatment in stage IIIA non-small cell lung cancerONCOLOGY LETTERS, 2017, 13 (03) : 1647 - 1654Palka, MagdaSanchez, AntonioCordoba, MarDiaz Nuevo, GemaVarela De Ugarte, AndresCantos, BlancaMendez, MiriamCalvo, VirginiaMaximiano, ConstanzaProvencio, Mariano
- [30] Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancerJOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (04) : 688 - 694Yasuda, HYamaya, MNakayama, KSasaki, TEbihara, SKanda, AAsada, MInoue, DSuzuki, TOkazaki, TTakahashi, HYoshida, MKaneta, TIshizawa, KYamanda, STomita, NYamasaki, MKikuchi, AKubo, HSasaki, H